• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RAPID MEDICAL LTD TIGERTRIEVER REVASCULAZATION DEVICE; TIGERTRIEVER 17

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RAPID MEDICAL LTD TIGERTRIEVER REVASCULAZATION DEVICE; TIGERTRIEVER 17 Back to Search Results
Model Number TIGERTRIEVER 17
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Vascular Dissection (3160)
Event Date 11/18/2023
Event Type  Death  
Manufacturer Narrative
Additional procedural details were obtained from the reporting physician on a teleconference that was held on november 27th, 2023.It was pointed out by the physician that it seems that the device got caught on an undetectable piece of calcium which prevented proper deflation and retrieval.The device was discarded after use and therefore not available for return and investigation, however it was mentioned by the physician that the device was intact and fully deflated when removed from the patient.The physician also mentioned during the call that the patient was pretreated with aggrastat, which could have resulted in an excess bleeding.Based on the results of the investigation, dhr review, and procedure details, there is no indication that the device, labeling or packaging failed to meet its specifications when released.Potential adverse events such as dissection and hemorrhage are included in the device labelling.Consequently, it was determined that the reported adverse event is anticipated complication.
 
Event Description
Rapid medical received a report regarding the tigertriever 17 device which was used for an acute ischemic stroke.After successful removal of a thrombus from the aca, the device was directed into the proximal mca segment.When trying to deflate the device, no reaction was detected.When removal was attempted, resistance was met.Ultimately the device was successfully removed, however a dissection was subsequently observed.As a result, hemorrhaging was noted in the area of treatment and the patient ultimately expired.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TIGERTRIEVER REVASCULAZATION DEVICE
Type of Device
TIGERTRIEVER 17
Manufacturer (Section D)
RAPID MEDICAL LTD
p.o.box 337
carmel building
yokneam, 20692 05
IS  2069205
Manufacturer (Section G)
RAPID MEDICAL LTD
p.o.box 337
carmel building
yokneam, 20692 05
IS   2069205
Manufacturer Contact
ina gutman
p.o.box 337
carmel building
yokneam, 20692-05
IS   2069205
MDR Report Key18235612
MDR Text Key329314711
Report Number3009957947-2023-00009
Device Sequence Number1
Product Code NRY
UDI-Device Identifier07290015107273
UDI-Public(01)07290015107273(17)240531(10)211223TS01
Combination Product (y/n)N
Reporter Country CodeIS
PMA/PMN Number
K203592
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign
Reporter Occupation Physician
Type of Report Initial
Report Date 11/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/30/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTIGERTRIEVER 17
Device Catalogue NumberTRPP7166
Device Lot Number211223TS01
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/21/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-